Pharmacokinetics and Pharmacodynamics of Glyburide/Metformin Tablets (Glucovance???) versus Equivalent Doses of Glyburide and Metformin in Patients with Type 2 Diabetes
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (15) , 1301-1309
- https://doi.org/10.2165/00003088-200241150-00004
Abstract
Objective To compare the effects of two different formulations of glibenclamide (glyburide) combined with metformin on postprandial glucose excursions, and to assess their pharmacokinetics. The...Keywords
This publication has 14 references indexed in Scilit:
- Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metforminDiabetic Medicine, 2002
- Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetesDiabetes, Obesity and Metabolism, 2002
- Postprandial Blood GlucoseDiabetes Care, 2001
- Pharmacokinetics and Bioavailability of a Metformin/Glyburide Tablet Administered Alone and with FoodThe Journal of Clinical Pharmacology, 2000
- Improved postprandial glycemic control with humalog® mix75/25™ after a standard test meal in patients with type 2 diabetes mellitusClinical Therapeutics, 2000
- Effects of glibenclamide and metformin (alone or in combination) on insulin release from isolated human pancreatic isletsActa Diabetologica, 1997
- Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled studyDiabetes Care, 1994
- Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in HumansDiabetes Care, 1991
- Sulphonylurea Antidiabetic DrugsDrugs, 1989
- Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil).1983